Partners Banner

Partners

Clinical Diagnostic Partners

Partner List
xMAP® Menu

Life Science Research Partners

Partner List
xMAP® Menu

Become a Luminex Partner

Business Development Opportunities

Luminex sells xMAP® Technology-based solutions through exclusive partners spanning a wide range of industries and specialties. These partners add value to our technology, create powerful, customizable kits and deliver world-class service and support. They also offer the industry, market and application expertise necessary to respond to user needs quickly and most effectively.

Partner xMAP Application Area
Abbott Molecular Diagnostics Molecular Diagnostics Distribution
Alere Immunodiagnostics
ARUP Laboratories Reference Laboratory Services
Asuragen Molecular Diagnostics
Aviir, Inc. Reference Laboratory Services
BMD Immunodiagnostics
Biodiagnostics Distribution
Bio-Rad Laboratories Immunodiagnostics
Celera Molecular Diagnostics
Fisher Healthcare Molecular Diagnostics Distribution
Gen-Probe HLA/Transplant
InGen Biosciences Immunodiagnostics
Inova Diagnostics Immunodiagnostics
ImmuneTech Allergy Testing (Human)
Innogenetics Immunodiagnostics
Interscientifica Immunodiagnostics
Laboratory Corporation of America Reference Laboratory Services
Mayo Foundation Reference Laboratory Services
Medical & Biological Laboratories HLA / Transplant and Oncology
Mikrogen Immunodiagnostics
Multimetrix Immunodiagnostics
North Shore-LIJ Health System, Inc. Reference Laboratory Services
One Lambda, Inc. HLA / Transplant
Progenika Blood Group Genotyping
Qiagen GmbH Women's Health
Quest Diagnostics Reference Laboratory Services
Ramcon Distribution
Tellgen Immunodiagnostics
Wakunaga Pharmaceutical HLA/Translplant
ZEUS Scientific Immunodiagnostics

 

Luminex sells xMAP® Technology-based solutions through exclusive partners spanning a wide range of industries and specialties. These partners add value to our technology, create powerful, customizable kits and deliver world-class service and support. They also offer the industry, market and application expertise necessary to respond to user needs quickly and most effectively.

Partner xMAP Application Area
Affymetrix Molecular Research and Immunoassay Research
Bio-Rad Laboratories Research Immunoassay
Cayman Chemical  Research Immunoassay
Charles River Labs Laboratory Animal Research Testing Services
Cornell University Testing Services (Animal Health)
EMD Millipore Research Immunoassay
G&G Science Company Testing Services
Hitachi Software Data Analysis Software, Testing Services
Indicia Biotechnology Custom Assay Development
Indoor Biotechnologies, Inc. Allergen Testing (Environmental)
Life Technologies Research Immunoassay
Origene Technologies Gene Expression
PerkinElmer Molecular Cytogenetics
Plant Research International Testing Services (Plant and Animal)
R&D Systems Research Immunoassay
Radix Biosolutions Custom Assay Development
Rules Based Medicine Research Immunoassay; Testing Services/Custom Assay Development
University of California, Davis Laboratory Animal Research Testing Services
University of Missouri  Veterinary Testing Services

 

 

 

 

Designed for Luminex Partners who are pursuing outsourced high-quality assay development as a way to expand their assay menu, the Luminex Certified Developer Program evaluates and certifies potential xMAP® assay developers against a set of specific, quality-driven criteria. The primary goal of the program is to establish a quality benchmark for assay development services on xMAP Technology.

Learn more about the Luminex Certified Developer Program:

 

 

 

 

 

 

 

 

 

 

 

Become a Luminex partner: xCCELERATE your success by harnessing the power of xMAP® Technology

Luminex’s unique licensing model allows our business partners to capitalize on opportunities in a broad spectrum of life science and clinical applications by accessing the world’s leading multiplex platform.

Luminex is committed to building strong, mutually rewarding partnerships with market leaders in key life science and diagnostic markets.

 

 

 

 

 

 

 

 

 

 

 


Share: